Nov 10 (Reuters)-
D.Western Therapeutics Institute Inc
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2022 Sep 30, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 309 mln 315 mln 370 mln
(-2.1 pct) (+31.3 pct) (-10.7 pct)
Operating loss 251 mln loss 114 mln loss 690 mln
Recurring loss 239 mln loss 105 mln loss 700 mln
Net loss 226 mln loss 101 mln loss 670 mln
EPS loss 7.70 yen loss 3.48 yen loss 22.82 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - D.Western Therapeutics Institute Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4576.T